Progyny Inc (PGNY)
Progyny, Inc. is a healthcare benefits management company focused on fertility, family building, and women’s health solutions in the United States. Its offerings include fertility benefits programs built around customized plan design, member support from dedicated care teams, and access to a curated network of fertility specialists. The company also provides Progyny Rx, an integrated pharmacy benefits solution that supports access to medications used during treatment and includes care management services. Additional services cover pregnancy and postpartum support, menopause and midlife benefits, leave and navigation assistance, and parent and child wellbeing programs. Progyny also administers reimbursement-based assistance for services such as adoption, surrogacy, doula support, and travel when medical care requires it. Founded in 2008 and based in New York, New York, the company was previously known as Auxogyn, Inc. before adopting the Progyny name in 2015.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-PGNY
|
$37.09
|
28.0% Upside
|
Undervalued
|
$34.42
|
18.8% Upside
|
Undervalued
|
Great
|
0.0%
|
28.3x
|
4.9x
|
1.7x
|
2.223 B
|
2.013 B
|
1.2%
|
91.5%
|
8.5
|
226.9%
|
